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Presentation of case
Dr. A.M. Goritschan: The black African patient had
immigrated from Lagos, Nigeria 18 months before
admission to Austria to join her husband, who had
immigrated to Austria 13 years earlier. Her travel his-
tory was negative since arrival in Austria; her medical
history was positive for arthralgia and a skin rash
2 years earlier, when she was still living in Nige-
ria. These symptoms were treated with unspecified
injections and oral medication for 5 days. The symp-
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toms subsided when she became pregnant with her
first child. After an unremarkable pregnancy and 4
months before the current admission she gave birth
to a second healthy child. The patient attended the
dermatology outpatient clinic 3 weeks before admis-
sion because of a skin rash on her back and fever.
She was diagnosed with folliculitis and an ointment
with a combination of betamethasone and gentam-
icin was prescribed for topical treatment. The rash
appeared on the hands and feet of the breast feed-
ing woman 2 weeks later with small skin lesions that
exsiccated after secretion of a milky exudate. The
patient reported fever, mainly during the night and
some improvement with paracetamol. An enlarged
firm lymph node was palpable in the left axilla. Serol-
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ogy for syphilis and human immunodeficiency virus
(HIV) was negative, as was direct examination for
scabies. The patient’s laboratory tests were notable
for hemoglobin 11.7 g/dl (normal: 12.0–15.3 g/dl),
hematocrit 34.8% (normal: 35.0–45.0%), alkaline
phosphatase 153U/l (normal: 35–105U/l), gamma-
glutamyl transferase (GGT) 42U/l (normal: <38U/l),
aspartate-amino transferase (AST) 37U/l (normal:
<30U/l), alanine aminotransferase (ALT) 49U/l (nor-
mal: <35U/l) and C-reactive protein (CRP) 37.3mg/l
(normal: <5.0mg/l). At the follow-up visit 2 weeks
later the patient reported worsening of her condition.
The skin rash was unchanged, but she additionally
complained of pain in both lower legs, the ankles
and her left foot were swollen. She still had noctur-
nal fever with temperatures up to 39.0 °C and there
was now a second palpable, indolent lymph node in
the right axilla. After one of the skin lesions on the
thighs was biopsied, the patient and her 4-month-old
daughter were admitted to the department of internal
medicine for further work-up.
The patient weighed 68 kg and her height was
170 cm with a body mass index (BMI) of 23.5 kg/m2,
her neck was supple, her blood pressure was
112/73mmHg, and the heart rate was 65 per minute
and regular. Except for the two palpable, axillary
lymph nodes and the follicular skin rash, the patient
complained of pain on firm palpation in both lower
legs; both ankles and feet were slightly swollen. The
rest of the physical examination was unremarkable,
as were the electrocardiogram and chest radiograph.
Native computed tomography (CT) of the chest re-
vealed an enlarged lymph node (3.0 × 3.6 cm) in the
right axilla. Magnetic resonance imaging (MRI) of the
mediastinum was unremarkable, but showed several
enlarged lymph nodes in the right axilla with a max-
imum diameter of 3.6 cm. Lymph nodes in the left
axilla were up to 8mm in diameter. Urinalysis and
urinary sediment were within normal limits. At this
time the patient’s laboratory tests were notable for
CRP 63mg/l (normal: <5mg/l), erythrocyte sedimen-
tation rate 86mm (normal: <20mm), total protein
7.9 g/dl (normal: 6–8 g/dl), alpha-1-globulin 3.7%
(normal: 1.5–3.5%), gammaglobulin 24.3% (10–18.5%)
and haptoglobin 3.75 g/l (normal: 0.3–2.0 g/l). The
histopathological findings for the skin biopsy showed
vasculitis suggesting polyarteritis nodosa but there
was no evidence of acute generalized exanthemic
pustulous dermatitis (AGEP). Immunopathological
parameters were negative; these included antinuclear
antibodies (ANA), antineutrophil cytoplasmic anti-
bodies against myeloperoxidase (ANCA-MPO) and
proteinase 3 (ANCA-Pr3), antibodies against double-
stranded DNA, mitochondria, smooth muscle cells
and basal membrane, and screening for extractable
nuclear antigens (ENA). At this time, treatment with
prednisolone (75mg daily) was commenced. Con-
sequently, nocturnal fever with recent temperatures
up to 40.1 °C disappeared and CRP decreased to
1mg/l. A blood culture obtained during the night
when the patient’s temperature was highest was neg-
ative. Serological tests for Borrelia burgdorferi, Bar-
tonella henselae, Yersinia Types 3 and 9, Toxoplasma
gondii, Chlamydia trachomatis, Mycoplasma pneumo-
niae, Epstein-Barr virus, Coxsackie A and B viruses,
cytomegaly virus, enterovirus, human herpes virus,
mumps and parvovirus B 19 were all negative or nor-
mal. Angiotensin-converting enzyme (ACE) was also
normal. Repeated measurements of procalcitonin
did not exceed 0.05 ng/ml (normal 0.03–0.05 ng/ml).
Fluorescence-activated cell sorting (FACS) did not in-
dicate a clonal cell population or cells with aberrant
expression of markers on leukocytes in the peripheral
blood.
A diagnostic test was performed.
Differential diagnosis
Dr. B. Schneeweiss: In essence, the patient under
discussion suffers from fever 3 months postpartum,
has a skin rash first diagnosed as folliculitis, which
presents with small skin lesions drying up after se-
cretion of a milky exudate. In a second phase of
the disease the skin manifestations spread over the
whole body and the patient developed pain on firm
palpation in both lower legs; the ankles and feet were
swollen. According to the protocol, the rash was not
diagnosed as erythema nodosum. Administration
of prednisolone markedly improved her symptoms,
a response that could point to a rheumatological
disease. This was, however, not confirmed by lab-
oratory data, which were only notable for elevated
CRP, blood sedimentation rate and gammaglobulin,
and revealed discrete anemia and slightly increased
transaminases. Several immunological parameters
and screening for ENA were negative, as were ACE,
blood cultures and serological tests for various in-
fections. The histopathological findings of the skin
biopsy revealed vasculitis and polyarteritis nodosa
was suspected. Since the skin lesions were described
to secrete milky exudate, Sweet’s syndrome should
also be considered in this case.
Furthermore, it is of utmost importance to address
the patient’s axillary lymphadenopathy. Depending
on the size and localization of the enlarged lymph
nodes, different diagnoses should be considered. Var-
ious sonographic criteria are available to distinguish
benign from malignant lymphadenopathy [1, 2]. Usu-
ally, lymphadenopathy is classified as benign if lymph
nodes have a diameter <1 cm and infectious and sys-
temic diseases can be excluded. Lymph nodes with
a diameter >2 cm often suggest malignancy; however,
regardless of the size, the underlying cause of a pro-
gression in size of lymph nodes should always be in-
vestigated.
In summary, the described symptoms and findings
strongly suggest the diagnosis of polyarteritis nodosa.
These include (1) lymphadenopathy, (2) swollen feet,
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Table 1 Causes for lymphadenopathycombinedwitha skin
rashasdescribed in thepatient























which occur in 80% of affected patients, and (3) fever,
which is observed in 25–30% of cases. Furthermore,
the prompt positive response to corticosteroids de-
scribed in this case is typical for polyarteritis nodosa
[3] as are normal immune parameters, such as AN-
CAs, also observed in this patient [4]. Approximately
50% of patients with polyarteritis nodosa present
with livedo reticulatis, which, however, is difficult
to diagnose in people with dark skin. On the other
hand, the histopathological finding of vasculitis in
this case does not strongly suggest polyarteritis no-
dosa, which is defined as necrotizing arteritis not
associated with ANCAs of medium or small arteries
without glomerulonephritis or vasculitis in arterioles,
capillaries or venules [5]. Additionally, no organ is
documented to be involved, which is also atypical
for polyarteritis nodosa. Thus, other causes for lym-
phadenopathy and bullous skin rash in relation to
rheumatological and infectious diseases have to be
considered (Table 1). Although systemic lupus ery-
thematosus (SLE) may present with negative serology
(as observed in the discussed patient), the course of
the disease in this case does not suggest SLE. Behcet’s
disease can also be excluded because this disease
does not occur in black people [6] and with negative
radiograph, CT and MRI, there are no indications for
a granulomatous disease such as Wegener’s granulo-
matosis or lymphomatoid granulomatosis. Although
serology was negative for various infections, at this
point infection with Mycobacterium tuberculosis can-
not be ruled out. In my experience this infection
can present with a wide range of symptoms. Other
diseases (Table 1) that might cause lymphadenopathy
and skin rash include inflammatory bowel disease
(IBD). Both are typical symptoms in IBD and in some
cases they present many years before intestinal man-
ifestations of the disease. Cutaneous symptoms in
IBD include vulvoperineal Crohn’s disease, genital
lymphedema, lymphangioma circumscripta, orofa-
cial granulomatosis, erythema nodosum, pyoderma
gangrenosum, peristomal pyoderma gangrenosum,
pyostomatitis vegetans, oral aphthous ulcers, Sweet’s
syndrome, leukocytoclastic vasculitis, cutaneous pol-
yarteritis nodosa and epidermolysis bullosa acquisita
[7]. Several cases of cutaneous polyarteritis nodosa in
Crohn’s disease have been described [7–9] and may
also be suspected here. It should also be considered
that cutaneous polyarteritis nodosa can be induced by
Mycobacterium tuberculosis [10]. This limits our pa-
tient’s diagnosis to IBD, most likely Crohn’s disease, or
mycobacterial infection. To finally establish the right
diagnosis in this case I would propose tests for tuber-
culosis including an interferon-gamma release assay
(IGRA), imaging studies of the abdomen and biopsy
of an axillary lymph node. Since the axillary lymph
nodes with a diameter up to approximately 4 cm are
highly pathological, I strongly suspect tuberculosis in
this patient.
Dr. B. Schneeweiss’s diagnosis
Tuberculosis.
Discussion of case
Dr. A. Aigelsreiter: A sonographically guided biopsy
of the enlarged right axillary lymph node was per-
formed in the breast center of the department of ob-
stetrics and gynecology. Histopathology revealed de-
stroyed lymph node structure, as well as necrotizing
caseating areas surrounded by epithelioid cell granu-
lomas and lymphocytes; multinucleated Langerhans
giant cells were also present (Fig. 1). Caseating gran-
ulomas are classically associated with mycobacterial
infections but can also occur with fungal infection
(e. g. histoplasmosis), tularemia and rarely sarcoido-
sis [11]. For the pathologist, two diagnoses have to be
primarily considered in this case with granulomatous
lymphadenitis: tuberculosis and sarcoidosis. Staining
for acid-fast bacilli was negative. PCR testing for My-
cobacterium tuberculosis was positive and finally led
to the diagnosis of lymph node tuberculosis.
Dr. G.J. Krejs: Dr. Flick is a specialist for tuberculo-
sis and will present the course of the disease in this
patient.
Dr. H. Flick: On firm diagnosis of lymph node tu-
berculosis, the patient received standard treatment
for tuberculosis with quadruple drug therapy (ri-
fampicin 600mg q.d., isoniazid 300mg q.d., pyrazi-
namide 1500mg q.d., ethambutol 1000mg q.d.) for 2
months and a 2-drug therapy (rifampicin 600mg q.d.,
isoniazid 300mg q.d.) for an additional 4 months.
Prednisolone was tapered but had to be reintroduced
(50mg per day) because her vasculitis had worsened.
After 2 months of treatment for tuberculosis, CT
showed that the enlarged axillary lymph nodes were
now much smaller. The patient became completely
free of symptoms and had gained weight under long-
term therapy with prednisolone. Currently, she is still
under two-drug therapy for tuberculosis and addi-
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Fig. 1 aOverviewof epithelioid cell granuloma. In thecenter a necrotizing caseating area (C) surroundedbyepithelioid cells and
lymphocytes,with amultinucleatedLangerhansgiant cell (L) (H&E, x20). bHighermagnificationof themultinucleatedLangerhans
giant cell in themiddle surroundedbyepithelioid cells and lymphocytes (H&E, x60)
Fig. 2 Skin rashon the
lower legswithmultiple
papulesup to 1.5 cm in
diameter. On the right leg
two largehyperpigmented
macules
tionally receives corticosteroids, which will be slowly
tapered during the next months.
Dr. G.J. Krejs: Therapy with corticosteroids in tuber-
culosis is considered dangerous and is usually avoided
because it could trigger spread of the infection.
Dr. B. Schneeweiss: To my knowledge, in addition
to the tuberculostatic therapy, patients with tubercu-
lous meningitis are also treated with corticosteroids
despite the infection with Mycobacterium tuberculo-
sis. In this case, however, the remarkably quick and
positive response of the patient to corticosteroids is
a surprising and interesting observation.
Dr. R. Hofmann-Wellenhof: When the patient first
presented at the dermatology outpatient clinic, her
skin condition was diagnosed as folliculitis, i. e. fol-
licular-associated inflammation. Folliculitis is fre-
quently observed in febrile diseases as reported by
the patient because of increased perspiration. After 3
weeks of local therapy with an ointment combining
steroids and antibiotics, the folliculitis disappeared
and the patient presented with a papulous rash (Fig. 2)
with lesions too small and superficial for erythema
nodosum. Histology of a biopsy taken from a skin
lesion on her thighs revealed dense infiltration of the
tissue with lymphocytes and macrophages in the cutis
and subcutis. Inflammation was mainly seen around
medium and small vessels (Fig. 3). Histology of the
skin lesion did not reveal granulomatous inflam-
mation or caseating granulomas. Superficial vessels
were not affected by inflammation as is typical for
superficial allergic vasculitis, which presents with su-
perficial necrotizing skin lesions. Clinical symptoms
and histopathology led to the diagnosis of polyarteri-
tis nodosa. This suspicion was further strengthened
by the patient’s positive response to corticosteroids.
Further tests, however, ultimately led to the diagnosis
of tuberculosis. Erythema induratum of Bazin, which
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Fig. 3 Histologyof a skin
biopsy revealeda vasculitis
ofamid-sizedvessel located
in the superficial subcuta-




sized vessel (H&E, x100)
is typically but rarely observed in tuberculosis and
characterized by large papulous plaques and inflam-
mation also affecting the subcutis was not found and
PCR of the skin biopsy for Mycobacterium tuberculo-
sis was negative. According to the literature, however,
pathogens are rarely detected in skin biopsy [12, 13].
Taking together the skin manifestations and lymph
node tuberculosis, the skin lesions have to be in-
terpreted as tuberculosis-associated immunologically
mediated vasculitis.
Dr. G.J. Krejs: Since the patient complained of
swollen and painful ankles, a rheumatologist was
consulted.
Dr. H.-P. Brezinsek: Diagnosis of a rheumatological
disease was quite difficult because the patient had al-
ready been under corticosteroid therapy and the an-
kle pain as well as the painful skin rash had subsided
when I examined her. Basically, tuberculosis can also
affect joints, especially the spine, hips and knees, but
these structures were not affected. In suspected cases,
joint puncture and PCR testing for Mycobacterium tu-
berculosis of the punctate should be performed to
confirm a joint affection by tuberculosis. Involvement
of the ankle joints and even the described course of
the joint symptoms in this patient would have been
very atypical for tuberculosis, so that it seems very
unlikely that the joint problems were indeed due to
tuberculosis; they are more compatible with sarcoido-
sis, e. g. Löfgren’s syndrome, but this syndrome also
includes erythema nodosum, which this patient did
not have. Because of the rapid response to the treat-
ment, we concluded that the symptoms were parain-
fectious. Unfortunately, no imaging studies (ultra-
sound or MRI) of her joints were made before cor-
ticosteroids were started. We can only speculate as
to whether her symptoms were just arthralgia, com-
monly seen during infections, or arthritis. Reactive
arthritis would be unlikely since the main criteria for
diagnosis [14], e. g. enteritis and urethritis, were not
present.
Dr. G.J. Krejs: Despite advances in diagnosis and
therapy, tuberculosis is still one of the world’s biggest
health threats and a major public health concern;
decades ago the World Health Organization estab-
lished a global tuberculosis monitoring system [15]. It
is of interest that in western countries, while the total
incidence of tuberculosis decreased, the proportion
of extrapulmonary tuberculosis increased from 8% in
1962 to 21% in 2015 [11, 16–18]. The most common
type of extrapulmonary tuberculosis is lymph node
tuberculosis followed by pleural, genitourinary, bone/
joint, miliary, meningeal and peritoneal manifestation
of the disease [19].
Dr. Flick will provide further epidemiological data
on tuberculosis, specifically focusing on the situation
in Austria.
Dr. H. Flick: According to the national reference
center for tuberculosis, the total number of cases
in Austria decreased from 1480 cases in 1997 to 582
in 2014, for a yearly incidence of 6.8 per 100,000
population. As in other high-income countries, the
incidence of tuberculosis is generally higher in for-
eign-born persons (31.2 per 100,000 population in
2014) than in Austrian-born persons (3.3 per 100,000
population in 2014), with 82% presenting with pul-
monary tuberculosis and 18% with extrapulmonary
manifestations [20]. The linear decrease of tuberculo-
sis incidence in Austria (-0.65 per 100,000 population
per year from 1997 to 2014) is attributable to a reduc-
tion of cases in native-born persons; the incidence
in foreign-born persons in Austria tends to decrease
only very slightly, and is still more than ten-fold higher
than in native-born persons. This discrepancy in the
incidence of tuberculosis among native-born and for-
eign-born persons may be explained by the fact that
in Austria transmission of tuberculosis is effectively
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limited by immediate isolation of infected patients.
This is important because each case of active tuber-
culosis is estimated to cause 10–20 further infections
[21]. In contrast, detection of active tuberculosis and
isolation of infected patients is not routine practice
in many low-income countries with lower health care
standards. Depending on the intensity of exposure to
Mycobacterium tuberculosis, up to 30% of individuals
are estimated to develop latent infection after contact
with an infectious index patient [22] and one third
of the world’s population is estimated to be latently
infected with Mycobacterium tuberculosis [23]. These
individuals carry a 5–10% lifetime risk of progressing
to active tuberculosis [24]. Treatment of latent infec-
tions with isoniazid reduces the risk of future disease
by 75–90% [25]. Undetected tuberculosis (active and
latent) is a major problem in low-income countries
and flight and migration of people from countries
with high tuberculosis incidence may additionally
enhance the risk of transmission among immigrants.
If a foreign-born patient (particularly from high in-
cidence regions such as Asia and Africa) presents with
fever and unclear symptoms, tuberculosis should be
suspected. The discussed patient came from Nige-
ria, where the yearly incidence of tuberculosis is
about 300–499 per 100,000 population [15]. Physi-
cians should be aware of tuberculosis, particularly
when clinical symptoms, travel history or migration
strongly suggest the disease. When tuberculosis is
suspected, a tissue biopsy should be examined with
acid-fast bacilli staining, culture, and PCR, as was
done in this case.
For the diagnosis of tuberculosis, it should be borne
in mind that both the tuberculin skin test (TST) and
interferon gamma release assay (IGRA) have highly
variable sensitivity, even in active cases of tuberculo-
sis. In patients with culture-confirmed tuberculosis,
the sensitivity of the TST ranges from 75–90%; how-
ever, cross-reactivity of the intradermally injected pu-
rified protein derivate of Mycobacterium bovis with
nontuberculous mycobacteria and the bacillus Cal-
mette Guérin vaccine limits the specificity of the test
in a population [26]. It has further been shown that
TST is negative in up to half of all cases of dissem-
inated tuberculosis [11]. The IGRA measures inter-
feron gamma response of the immune system to infec-
tion in blood samples using highly specific Mycobac-
terium tuberculosis antigens, thus providing improved
specificity over TST [27, 28]. However, IGRA lacks the
sensitivity that is routinely demanded from other lab-
oratory tests; false negative test results are reported in
up to 25% of cases [27]. Both TST and IGRA do not
provide information on whether the disease is active
or latent and a negative test does not exclude tubercu-
losis. False negative results may delay the correct di-
agnosis and treatment because physicians will prob-
ably want to rule out infection with Mycobacterium
tuberculosis early and then search for other causes of
disease. In this patient the IGRA was first negative
and later, after the diagnosis was already established,
became positive.
As observed here, immunological reactions and
vasculitis in various organs are very rare, but well
described. Depending on the affected organ, this
can cause severe health problems in tuberculosis,
especially when the central nervous system (CNS) is
involved. To reduce the risk of increased immune re-
actions leading to vasculitis, concurrent therapy with
anti-tuberculous drugs and corticosteroids is recom-
mended in CNS tuberculosis [29, 30]. In other cases
of tuberculosis, administration of corticosteroids is,
however, controversial because it may worsen the re-
sponse to tuberculosis therapy due to the modulation
of immune reactions.
Dr. G.J. Krejs: Dr. Harnoncourt as a pulmonologist
will briefly report his experience with tuberculosis.
Dr. K. Harnoncourt: This case reminds me of a 65-
year-old nun with lymph node tuberculosis whom
I treated almost 60 years ago. She presented with an
enlarged lymph node and poor general health. Since
tuberculosis was suspected, a lymph node biopsy was
tested for Mycobacterium tuberculosis. Back then this
was done in animals, i. e. mice were inoculated with
material obtained from the patient. Approximately
6 weeks later this “bioassay” proved Mycobacterium
tuberculosis infection in our patient. In the 1950s pa-
tients received a two-drug antituberculous standard
therapy (isoniazid and streptomycin) for 6 months
with a reduction in dosage after 4 months.
Dr. A. Rosenkranz: As already mentioned, extrapul-
monary tuberculosis generally carries little risk for
transmission. In this case, even breastfeeding did not
transmit the disease to the baby, which was tested
after the mother’s diagnosis had been established.
Under quadruple antituberculous therapy, however,
the baby had to be weaned. Regarding the risk of
transmission, I would like to mention that normal
serum procalcitonin levels as observed in our patient
rather suggest an immunological than an infectious
cause of her symptoms [31].
Dr. G.J. Krejs: In 2017 tuberculosis remains an im-
portant diagnostic consideration. In the 30-year-his-
tory of our clinical-pathological conference (CPC) se-
ries from theMedical University of Graz, including this
case we discussed a total of 5 cases of tuberculosis, or
3% of all CPCs. There were two cases of tuberculous
peritonitis, one of tuberculous spondylodiscitis, one
of ileocecal tuberculosis, and the current patient, who
suffered from lymph node tuberculosis.
Dr. B. Schneeweiss: This case clearly highlights that
even in 2017 tuberculosis should be considered when
a patient presents with fever and unclear symptoms,
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particularly when coming from a country in which the
disease is endemic.
Final diagnosis
Lymph node tuberculosis, tuberculosis-associated
vasculitis mimicking polyarteritis nodosa.
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